ENTA Enanta Pharmaceuticals, Inc.

NASDAQ
$7.62

Enanta Pharmaceuticals, Inc. (ENTA) Earnings News

Earnings press releases, previews and reviews for Enanta Pharmaceuticals, Inc. (ENTA), newest first. Our most recent is preview: Enanta Heads Into September-Quarter Report With Stock Near Lows and Wider Loss Expected.